Major Investment to Transform Mental Health Research Français
OTTAWA, ON, June 19, 2025 /CNW/ - Brain Canada is proud to announce its support for the development of the Brain Imaging Centre Advanced Multi-modal neuroimaging Platform for Psychiatry (BIC-AMPP) at The Royal Ottawa Health Care Group's BIC. Through its 2024 Platform Support Grants (PSG) program, Brain Canada is partnering with The Royal to invest $1.9 million in this groundbreaking initiative, which will integrate multiple brain imaging modalities to revolutionize mental health research.
Led by Dr. Georg Northoff of the University of Ottawa's Institute of Mental Health Research (IMHR), the BIC-AMPP project brings together experts in MRI, PET, and EEG imaging to unlock the complex biochemical, structural, and functional changes associated with mental illness. This rare and technically advanced platform will allow researchers to simultaneously capture a more thorough and integrated picture of the brain, laying the groundwork for improved diagnostics and personalized treatments.
"This investment represents a step-change in the capabilities of our team and our infrastructure, positioning Canada at the forefront of brain imaging research for mental health," said Dr. Florence Dzierszinski, President and CEO of the IMHR and vice-president of research at The Royal. "Simultaneous tri-modal imaging is only being actively pursued in two other centres in the world, yet offers endless possibilities with the right technology and skills."
"This platform will enable us to link brain structure, chemistry, and function in real time," said Katie Dinelle, Administrative Director of The Royal's Clinical Brain Research Centre. "It will give us a more complete picture of mental illness and open new doors for discovery."
"Mental health research has long been limited by our inability to fully understand how the brain's structure, chemistry, and function interact," said Dr. Georg Northoff, lead Principal Investigator for the BIC-AMPP. "By integrating multiple imaging modalities in a single platform, we can finally start to connect the dots. This will help us move beyond fragmented insights toward a more holistic understanding of mental illness—one that can inform better, more personalized treatments."
The BIC-AMPP platform is designed to foster collaboration among scientists and provide unprecedented access to simultaneous multi-modal imaging, positioning The Royal as a hub for innovation and knowledge mobilization. Supported by expert scientific staff and a secure, open-access data-sharing infrastructure, the platform will accelerate discoveries that improve mental health care in Canada and beyond. Dr. Viviane Poupon, President and CEO of Brain Canada, emphasized the importance of this initiative: "The BIC-AMPP represents a major leap forward in our ability to understand mental illness and develop personalized treatments. Brain Canada is proud to support this visionary platform, which underlines Canada's position as a global leader in brain imaging research."
Brain Canada is contributing over $18 million in this year's PSG program through the Canada Brain Research Fund (CBRF), funded by Health Canada, as well as matching donations from sponsors for a total investment of $36.8 million. By enabling access to cutting-edge tools and specialized skills beyond the reach of individual researchers, the PSG program plays a vital role in strengthening the research landscape.
"Research and innovation deepen our understanding, unlock new treatments, and improve quality of life for people affected by mental illness," said the Honourable Marjorie Michel, Minister of Health. "Through the Canada Brain Research Fund, the Government of Canada is pleased to support this initiative, bringing together experts from different fields to accelerate discoveries that will improve mental health care for Canadians."
Over the coming weeks, Brain Canada will unveil the full list of 14 research platforms selected to receive PSG funding. The total investment of $36.8 million represents a major step forward in Canada's ability to support cutting-edge brain research and improve outcomes for people living with brain-disorders. For more information, please visit www.braincanada.ca.
The Royal is one of Canada's foremost mental health care, teaching, and research hospitals and is home to the Royal Ottawa Mental Health Centre, the Brockville Mental Health Centre, the University of Ottawa Institute of Mental Health and the Royal Ottawa Foundation for Mental Health. Our mission is to transform the lives of people living with complex mental illness and addictions. Learn more about The Royal, our services, and our impact.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CTV News
11 hours ago
- CTV News
Major investment for The Royal Clinical Brain Research Centre to understand mental illness, addiction
The Royal Ottawa Mental Health Centre unveiled one of the world's most advanced brain imaging technology to better understand mental illness and addiction. (Kimberley Fowler/ CTV News Ottawa) On Thursday, The Royal Ottawa Mental Health Centre unveiled one of the world's most advanced brain imaging technology to better understand mental illness and addiction. It's a state-of-the-art neuroimaging platform, promising to put Canada at the forefront of global brain research. In partnership with Brain Canada, The Royal is announcing a $1.9 million grant to launch a first-of-its-kind brain imaging platform in Canada, giving researchers a new look inside the brain and creating the opportunity to transform mental health research. Brain Canada president and CEO, Dr. Viviane Poupon says: 'I'm a neuroscientist by training, so for me to see the future of neuroscience, the breakthroughs that are going to happen, and building capacity for the researchers, for me is always amazing.' 'We're super excited to get to continue to grow this facility,' said Katie Dinelle, The Royal's administrative director of the Clinical Brain Research Centre. 'It has been here since 2016, and this is a big 'next step' for us.' The state-of-the-art neuroimaging platform allows researchers to scan the brain three ways at once. An MRI (Magnetic Resonance Imaging) provides detailed images of the brain, a PET (Positron Emission Tomography) acts a radioactive tracer to show brain activity and function, and an EEG (Electroencephalography) to measure electrical activity in the brain in real time. Only three teams in the world use this brain scanning technology for an unprecedented look at how the brain works. 'The idea with this grant is to combine all three of those imaging modalities to give us a very whole picture of the brain,' said Dinelle. Dr. Georg Northoff, senior scientist at The Royal and Psychiatry professor at the University of Ottawa says 'with depression you're extremely sad, you have anxiety disorders, also your sense of self can be very different, or you see yourself only as negative. So, understanding the basic mental brain-mind connection for basic mental features also implies that we can learn something from mental disorders.' The multi-modal imaging will also help researchers improve diagnostics and personalized treatments for mental health patients.
Cision Canada
15 hours ago
- Cision Canada
Major Investment to Transform Mental Health Research Français
OTTAWA, ON, June 19, 2025 /CNW/ - Brain Canada is proud to announce its support for the development of the Brain Imaging Centre Advanced Multi-modal neuroimaging Platform for Psychiatry (BIC-AMPP) at The Royal Ottawa Health Care Group's BIC. Through its 2024 Platform Support Grants (PSG) program, Brain Canada is partnering with The Royal to invest $1.9 million in this groundbreaking initiative, which will integrate multiple brain imaging modalities to revolutionize mental health research. Led by Dr. Georg Northoff of the University of Ottawa's Institute of Mental Health Research (IMHR), the BIC-AMPP project brings together experts in MRI, PET, and EEG imaging to unlock the complex biochemical, structural, and functional changes associated with mental illness. This rare and technically advanced platform will allow researchers to simultaneously capture a more thorough and integrated picture of the brain, laying the groundwork for improved diagnostics and personalized treatments. "This investment represents a step-change in the capabilities of our team and our infrastructure, positioning Canada at the forefront of brain imaging research for mental health," said Dr. Florence Dzierszinski, President and CEO of the IMHR and vice-president of research at The Royal. "Simultaneous tri-modal imaging is only being actively pursued in two other centres in the world, yet offers endless possibilities with the right technology and skills." "This platform will enable us to link brain structure, chemistry, and function in real time," said Katie Dinelle, Administrative Director of The Royal's Clinical Brain Research Centre. "It will give us a more complete picture of mental illness and open new doors for discovery." "Mental health research has long been limited by our inability to fully understand how the brain's structure, chemistry, and function interact," said Dr. Georg Northoff, lead Principal Investigator for the BIC-AMPP. "By integrating multiple imaging modalities in a single platform, we can finally start to connect the dots. This will help us move beyond fragmented insights toward a more holistic understanding of mental illness—one that can inform better, more personalized treatments." The BIC-AMPP platform is designed to foster collaboration among scientists and provide unprecedented access to simultaneous multi-modal imaging, positioning The Royal as a hub for innovation and knowledge mobilization. Supported by expert scientific staff and a secure, open-access data-sharing infrastructure, the platform will accelerate discoveries that improve mental health care in Canada and beyond. Dr. Viviane Poupon, President and CEO of Brain Canada, emphasized the importance of this initiative: "The BIC-AMPP represents a major leap forward in our ability to understand mental illness and develop personalized treatments. Brain Canada is proud to support this visionary platform, which underlines Canada's position as a global leader in brain imaging research." Brain Canada is contributing over $18 million in this year's PSG program through the Canada Brain Research Fund (CBRF), funded by Health Canada, as well as matching donations from sponsors for a total investment of $36.8 million. By enabling access to cutting-edge tools and specialized skills beyond the reach of individual researchers, the PSG program plays a vital role in strengthening the research landscape. "Research and innovation deepen our understanding, unlock new treatments, and improve quality of life for people affected by mental illness," said the Honourable Marjorie Michel, Minister of Health. "Through the Canada Brain Research Fund, the Government of Canada is pleased to support this initiative, bringing together experts from different fields to accelerate discoveries that will improve mental health care for Canadians." Over the coming weeks, Brain Canada will unveil the full list of 14 research platforms selected to receive PSG funding. The total investment of $36.8 million represents a major step forward in Canada's ability to support cutting-edge brain research and improve outcomes for people living with brain-disorders. For more information, please visit The Royal is one of Canada's foremost mental health care, teaching, and research hospitals and is home to the Royal Ottawa Mental Health Centre, the Brockville Mental Health Centre, the University of Ottawa Institute of Mental Health and the Royal Ottawa Foundation for Mental Health. Our mission is to transform the lives of people living with complex mental illness and addictions. Learn more about The Royal, our services, and our impact.
Cision Canada
7 days ago
- Cision Canada
UBC researchers awarded more than $6.5 million from Brain Canada to advance neuroscience research Français
VANCOUVER, BC, June 13, 2025 /CNW/ - UBC Faculty of Medicine researchers have been awarded more than $6.5 million from Brain Canada's Platform Support Grants program to support two pioneering neuroscience research platforms. The funding will help accelerate discovery and foster open science, positioning Canada at the forefront of global brain and spine health innovation. The two newly funded platforms are: International Spinal Cord Injury Biobank (ISCIB): Promoting Global Spinal Cord Injury Research Through Human Biobanking, led by Dr. Brian Kwon, which will expand access to vital human biological samples for spinal cord injury research, enabling researchers worldwide to advance treatments and improve outcomes for patients. Total Grant Awarded: $1,866,750 The University of British Columbia Genes, Cells and Circuits (UBC-GC2) Platform for Next-Generation Multiscale Brain Research, led by Dr. Mark Cembrowski, which will integrate state-of-the-art technologies to map brain function and connectivity from molecules to entire circuits, unlocking insights into complex brain disorders. Total Grant Awarded: $4,845,000 "This platform represents a critical step toward advancing spinal cord injury research globally," said Dr. Brian Kwon, a Professor in the Department of Orthopaedics and the Director of ICORD. "By providing access to high-quality human biosamples, we're enabling researchers worldwide to develop and test new treatments that could dramatically improve quality of life for patients." "With the UBC-GC2 platform, we're bridging the gap between molecular biology and systems neuroscience," said Dr. Mark Cembrowski, an Associate Professor in the Department of Cellular and Physiological Sciences. "By integrating cutting-edge technologies, we'll be able to study brain function at an unprecedented scale and resolution. This will not only advance our understanding of brain disorders but also open new avenues for treatments." These platforms exemplify UBC's commitment to advancing neuroscience and fostering collaboration within and beyond Canada's borders. "The UBC neuroscience community is grateful for Brain Canada's continued support," said Dr. Lynn Raymond, Co-Director of the Djavad Mowafaghian Centre for Brain Health at UBC. "These investments will strengthen our capacity to deliver world-class research and transform brain health for people across the lifespan." Viviane Poupon, President and CEO of Brain Canada, emphasized the importance of these initiatives: "By supporting these cutting-edge platforms, Brain Canada is building the infrastructure that will accelerate brain and spinal cord research and foster open science collaboration. We're proud to partner with UBC to drive innovations that will impact millions of lives." These two platforms are part of Brain Canada's broader Platform Support Grants (PSG) initiative, which has already invested in numerous projects across Canada to empower researchers with shared tools, data resources, and collaborative opportunities. The full list of funded platforms will be unveiled later this month. Brain Canada is contributing over $18 million in this year's PSG program through the Canada Brain Research Fund (CBRF), funded by Health Canada, as well as matching donations from sponsors for a total investment of $36.8 million. By enabling access to cutting-edge tools and specialized skills beyond the reach of individual researchers, the PSG program plays a vital role in strengthening the research landscape. "Research and innovation are essential to unlocking new treatments, improving recovery, and enhancing quality of life for people affected by brain health issues and injuries," said the Honourable Marjorie Michel, Minister of Health. "Through the Canada Brain Research Fund, the Government of Canada is very pleased to support these new neuroscience research platforms, which bring together experts from different fields, integrate cutting-edge technologies and focus on improving patient outcomes."
